EssilorLuxottica to acquire Optegra clinics,
another leap forward in its med-tech strategy

Acquisition of leading ophthalmology platform from MidEuropa will advance the Group’s development
of the most comprehensive and digital-forward patient journey


Paris, France and London, United Kingdom (30 May 2025) – EssilorLuxottica and MidEuropa
announced today they entered into an agreement for EssilorLuxottica to acquire Optegra, a fast-growing
and highly integrated ophthalmology platform operating in five key European markets: the UK, Czech
Republic, Poland, Slovakia and the Netherlands.

The acquisition represents a significant milestone in EssilorLuxottica’s med-tech strategy, building on
the Group’s offering which today spans far beyond frames and lenses to include AI-powered innovative
technologies, wearables, medical instruments and science-backed eyecare solutions that improve the
lives of millions of people.

The Optegra group, under the Optegra, Lexum and Iris brands, operates an extensive network of over
70 eye hospitals and diagnostic facilities across Europe, offering medically necessary ophthalmic
treatments and elective vision correction procedures supported by AI in pre- and post-op stages. These
include sight-saving cataract surgery, age-related macular degeneration and glaucoma treatments,
refractive lens replacement and laser eye surgery, serving both publicly reimbursed and private-pay
patients. Since 2007, its highly ranked surgeons and dedicated medical teams have established a strong
foundation of clinical leadership and a trusted reputation for quality care and industry-leading outcomes,
making the Optegra platform a natural fit for EssilorLuxottica’s expanding med-tech portfolio.


“With the acquisition of Optegra, we are stepping into a new frontier – one where comprehensive
eyecare, advanced diagnostics, therapeutic interventions and surgical treatments come together in one
seamless platform. We have the strategic assets to fuel this vision: an extensive distribution network
with new clinical approaches, a smart eyewear offering with healthcare potential, and diagnostic
capabilities that will be able to detect conditions ranging from neurodegenerative diseases to
cardiovascular dysfunction. Optegra and its experienced doctors will bring new medical capabilities to
our Group, enabling us to address patients’ needs with the most advanced vision care technologies and
treatments in one trusted system that will anchor our med-tech aspirations. Powered by our growing AI
and big data capabilities, we will be able to broaden our impact and deliver the most personalized and
seamless patient journey,” commented Francesco Milleri, Chairman and Chief Executive Officer, and
Paul du Saillant, Deputy Chief Executive Officer at EssilorLuxottica.


“Optegra’s evolution under MidEuropa’s ownership reflects our approach to supporting high-quality
European healthcare platforms with strong growth potential. We partnered with Peter Byloos and his
experienced leadership team to accelerate the company’s organic expansion and successfully entered
two new markets, the Netherlands and Slovakia. We supported the opening of new clinics in the UK and
completed eight strategic add-on acquisitions across five countries. We are proud to have contributed
to Optegra’s digitalization, implementation of AI technologies, and broader mission to expand access to
high-quality eye care. We would like to thank the management team and clinical staff for their dedication
and ambition throughout this journey. We believe EssilorLuxottica is the ideal partner to lead Optegra
into its next phase of growth and innovation, and we wish them every success as they build on the
strong foundation we have helped create,” commented Robert Knorr, Managing Partner at MidEuropa.




1/2
“Joining forces with EssilorLuxottica marks a transformative chapter for Optegra. Their global leadership
in vision care, combined with our clinical excellence and patient-centric approach, creates an innovative
platform to redefine the paradigm of ophthalmic services. This partnership not only accelerates our
growth potential but also enhances our ability to deliver advanced, digital and integrated eyecare
solutions to all our patients. It also creates a significant opportunity for our clinical team, our staff and
leadership to be part of a global and inspiring leader in vision care,” commented Dr. Peter Byloos, Chief
Executive Officer of Optegra Eye Health Care.


The transaction is expected to close later in 2025 pending regulatory approvals and other customary
closing conditions.



About EssilorLuxottica
EssilorLuxottica is a global leader in the design, manufacture and distribution of advanced vision care products, eyewear and med-tech solutions.
Its Mission is to help people around the world to see more and be more by addressing their evolving vision needs, personal style aspirations and
desire to feel more connected to the world around them. EssilorLuxottica is home to the most innovative lens technologies, including Varilux, Stellest
and Transitions, iconic brands such as Ray-Ban, Oakley and Supreme, the most desired luxury licensed brands and world-class retailers including
Sunglass Hut, LensCrafters, Vision Express and Apollo. Backed by robust R&D investments, distinctive capabilities and a top-quality asset portfolio,
the Company drives innovation across categories, from cutting-edge medical instruments and solutions for eye health to category-defining smart
glasses, all of which push the boundaries of the industry and reimagine the eyes as a gateway to new possibilities. With over 200,000 employees
across 150 countries, 600 operations facilities and 18,000 stores, the Group generated consolidated revenue of Euro 26.5 billion in 2024. Its
OneSight EssilorLuxottica Foundation has given access to sustainable vision care to nearly 1 billion people in underserved communities.
EssilorLuxottica trades on the Euronext Paris market and is included in the Euro Stoxx 50 and CAC 40 indices. Codes and symbols: ISIN:
FR0000121667; Reuters: ESLX.PA; Bloomberg: EL:FP. www.essilorluxottica.com

About MidEuropa
MidEuropa is a leading European private equity investor with deep roots in Central Europe and a long-term track record in the region spanning over
25 years. Headquartered in London, with offices in Warsaw and Bucharest, MidEuropa adopts a flexible pan-European and global approach to
identify winning investments across the healthcare, consumer, services, and technology sectors. MidEuropa works collaboratively with talented
founders and management teams to support and facilitate sustainable growth through buy & build, organic growth acceleration, digital transformation,
sustainability leadership, and international expansion to drive transformative growth and build industry champions. To date, MidEuropa has raised
and managed funds of over €6.5 billion, and completed 46 investments and over 280 add-on acquisitions across 20 countries. www.mideuropa.com

About Optegra
Optegra Eye Health Care is a specialist provider of ophthalmic services. Established in 2007, it has completed over one million eye procedures from
its 70 eye hospitals across the UK, Czech Republic, Poland, Slovakia and Holland. As well as providing private vision correction treatments – from
lens replacement and laser eye surgery to implantable contact lenses – Optegra treats cataract surgery both privately and through its partnership it
NHS England. Optegra also treats medical conditions Age-Related Macular Degeneration (AMD) and glaucoma; and has launched the first-ever
treatment for people with the Dry form of AMD. Optegra brings together leading-edge research, renowned surgeons and medical expertise, state-
of-the-art surgical equipment and AI-powered innovations. It performs more than 140,000 treatments annually, both private and publicly funded, with
industry-leading outcomes. www.optegra.com




EssilorLuxottica Communications MidEuropa Communications
Marco Catalani Citigate Dewe Rogerson
Head of Corporate Communications Agnes Riousse / Jonah Boon
media@essilorluxottica.com MidEuropa@citigatedewerogerson.com

EssilorLuxottica Investor Relations Optegra Communications
Giorgio Iannella Charlotte Sutton
Head of Investor Relations PR Consultant
ir@essilorluxottica.com charlotte.sutton@optegra.com